XVIVO Perfusion AB Revenue and Competitors

Claim your profile

Gothenburg, Sweden

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • XVIVO Perfusion AB's estimated annual revenue is currently $17.5M per year.(i)
  • XVIVO Perfusion AB's estimated revenue per employee is $155,000

Employee Data

  • XVIVO Perfusion AB has 113 Employees.(i)
  • XVIVO Perfusion AB grew their employee count by 20% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$91M58761%N/AN/A
#2
$21.7M14019%N/AN/A
#3
$29.1M18821%N/AN/A
#4
$11M7137%N/AN/A
#5
$10.9M70-27%N/AN/A
#6
$17.5M11320%N/AN/A
#7
$27.6M17827%N/AN/A
#8
$9.3M6036%N/AN/A
#9
$8.7M56115%N/AN/A
#10
$4.8M31-18%N/AN/A

XVIVO Perfusion is a medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. We are committed to providing our customers with solutions and systems that can improve the transplant process outcome, facilitate the work for the transplant team, and enhance the long-term outcomes and quality of life of the transplant recipient. We believe nobody should have to die waiting for a new organ.

keywords:N/A

N/A

Total Funding

113

Number of Employees

$17.5M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

XVIVO Perfusion AB News

2022-04-17 - XVIVO Submits an IDE Application to US FDA for Its Innovative ...

GOTHENBURG, SE / ACCESSWIRE / April 27, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV). XVIVO proudly announces the filing of an...

2022-04-17 - XVIVO Presents Interim Report January-March 2022

GOTHENBURG, SWEDEN / ACCESSWIRE / April 25, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV). Strong sales growth and key milestones...

2022-04-17 - Bulletin from Annual General Meeting in XVIVO Perfusion AB ...

GOTHENBURG, SE / ACCESSWIRE / April 26, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV). The following resolutions were passed at...

2019-09-12 - Target Weight of 0.0278 Is Suggested For Xvivo Perfusion AB (publ) (OM:XVIVO)

According to the latest data, Xvivo Perfusion AB (publ) (OM:XVIVO) has a current suggested portfolio ownership tally of 0.0278 (as a decimal) ...

2019-09-12 - Quant Data & Earnings in Focus For Xvivo Perfusion AB (publ) (OM:XVIVO), AhnLab, Inc. (KOSDAQ:A053800)

In taking a look at some key indicators for Xvivo Perfusion AB (publ) (OM:XVIVO), we note that the current Book to Market value for the firm is at ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.3M12576%N/A
#2
$45.5M1383%N/A
#3
$41.4M16971%$7.5M
#4
$49.9M172110%$30.9M
#5
$64.1M22015%N/A